お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、抗凝固剤の世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に抗凝固剤市場を分類しています。
本レポートでは世界の抗凝固剤市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Bayer、Boehringer Ingelheim、Bristol-Myers Squibb、Daiichi Sankyo、Pfizer、Johnson & Johnson、Sanofi、AstraZeneca、Eli Lilly、Keryx Biopharmaceuticals

レポートは抗凝固剤の主要生産者を調査し、主要地域や国の消費状況も提供します。抗凝固剤の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Oral
    Injectable

用途別の市場セグメント：
    DVT
    PE
    AF

本レポートの詳細内容
本レポートは、世界の抗凝固剤市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて抗凝固剤市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）の抗凝固剤生産量、成長率、市場シェアを調査している。

二. 消費面では、抗凝固剤の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーの抗凝固剤売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の抗凝固剤市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本抗凝固剤のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：抗凝固剤のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章： 抗凝固剤の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおける抗凝固剤の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章抗凝固剤メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：抗凝固剤の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：抗凝固剤の主要メーカーの概要を提供し、製品の説明と仕様、抗凝固剤の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：抗凝固剤の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
The global Anticoagulant market is projected to grow from US$ 2630.7 million in 2024 to US$ 3774.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period.
Market competition is intense. Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson, Genentech (Roche) and Boehringer Ingelheim etc. are the leaders of the industry, with about 64% market shares.
North America is the largest consumption place, with a consumption market share nearly 39%. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.
Report Covers:
This report presents an overview of global market for Anticoagulant, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Anticoagulant, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Anticoagulant, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Anticoagulant sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Anticoagulant market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Anticoagulant sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Pfizer, Johnson & Johnson, Sanofi, AstraZeneca and Eli Lilly, etc.

Market Segmentation
By Company
    Bayer
    Boehringer Ingelheim
    Bristol-Myers Squibb
    Daiichi Sankyo
    Pfizer
    Johnson & Johnson
    Sanofi
    AstraZeneca
    Eli Lilly
    Keryx Biopharmaceuticals

Segment by Type
    Oral
    Injectable

Segment by Application
    DVT
    PE
    AF

Segment by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Anticoagulant in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Anticoagulant manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anticoagulant sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
    Table 1. Global Anticoagulant Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Oral
    Table 3. Major Manufacturers of Injectable
    Table 4. Global Anticoagulant Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Anticoagulant Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Anticoagulant Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Anticoagulant Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Anticoagulant Revenue Market Share by Region (2019-2024)
    Table 9. Global Anticoagulant Revenue Market Share by Region (2025-2030)
    Table 10. Global Anticoagulant Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Anticoagulant Sales by Region (2019-2024) & (K Units)
    Table 12. Global Anticoagulant Sales by Region (2025-2030) & (K Units)
    Table 13. Global Anticoagulant Sales Market Share by Region (2019-2024)
    Table 14. Global Anticoagulant Sales Market Share by Region (2025-2030)
    Table 15. Global Anticoagulant Sales by Manufacturers (2019-2024) & (K Units)
    Table 16. Global Anticoagulant Sales Share by Manufacturers (2019-2024)
    Table 17. Global Anticoagulant Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Anticoagulant Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Anticoagulant, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Anticoagulant Price by Manufacturers 2019-2024 (USD/Unit)
    Table 21. Global Anticoagulant Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Anticoagulant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticoagulant as of 2023)
    Table 23. Global Key Manufacturers of Anticoagulant, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Anticoagulant, Product Offered and Application
    Table 25. Global Key Manufacturers of Anticoagulant, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Anticoagulant Sales by Type (2019-2024) & (K Units)
    Table 28. Global Anticoagulant Sales by Type (2025-2030) & (K Units)
    Table 29. Global Anticoagulant Sales Share by Type (2019-2024)
    Table 30. Global Anticoagulant Sales Share by Type (2025-2030)
    Table 31. Global Anticoagulant Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Anticoagulant Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Anticoagulant Revenue Share by Type (2019-2024)
    Table 34. Global Anticoagulant Revenue Share by Type (2025-2030)
    Table 35. Anticoagulant Price by Type (2019-2024) & (USD/Unit)
    Table 36. Global Anticoagulant Price Forecast by Type (2025-2030) & (USD/Unit)
    Table 37. Global Anticoagulant Sales by Application (2019-2024) & (K Units)
    Table 38. Global Anticoagulant Sales by Application (2025-2030) & (K Units)
    Table 39. Global Anticoagulant Sales Share by Application (2019-2024)
    Table 40. Global Anticoagulant Sales Share by Application (2025-2030)
    Table 41. Global Anticoagulant Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Anticoagulant Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Anticoagulant Revenue Share by Application (2019-2024)
    Table 44. Global Anticoagulant Revenue Share by Application (2025-2030)
    Table 45. Anticoagulant Price by Application (2019-2024) & (USD/Unit)
    Table 46. Global Anticoagulant Price Forecast by Application (2025-2030) & (USD/Unit)
    Table 47. US & Canada Anticoagulant Sales by Type (2019-2024) & (K Units)
    Table 48. US & Canada Anticoagulant Sales by Type (2025-2030) & (K Units)
    Table 49. US & Canada Anticoagulant Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Anticoagulant Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Anticoagulant Sales by Application (2019-2024) & (K Units)
    Table 52. US & Canada Anticoagulant Sales by Application (2025-2030) & (K Units)
    Table 53. US & Canada Anticoagulant Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Anticoagulant Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Anticoagulant Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Anticoagulant Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Anticoagulant Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Anticoagulant Sales by Country (2019-2024) & (K Units)
    Table 59. US & Canada Anticoagulant Sales by Country (2025-2030) & (K Units)
    Table 60. Europe Anticoagulant Sales by Type (2019-2024) & (K Units)
    Table 61. Europe Anticoagulant Sales by Type (2025-2030) & (K Units)
    Table 62. Europe Anticoagulant Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Anticoagulant Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Anticoagulant Sales by Application (2019-2024) & (K Units)
    Table 65. Europe Anticoagulant Sales by Application (2025-2030) & (K Units)
    Table 66. Europe Anticoagulant Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Anticoagulant Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Anticoagulant Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Anticoagulant Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Anticoagulant Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Anticoagulant Sales by Country (2019-2024) & (K Units)
    Table 72. Europe Anticoagulant Sales by Country (2025-2030) & (K Units)
    Table 73. China Anticoagulant Sales by Type (2019-2024) & (K Units)
    Table 74. China Anticoagulant Sales by Type (2025-2030) & (K Units)
    Table 75. China Anticoagulant Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Anticoagulant Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Anticoagulant Sales by Application (2019-2024) & (K Units)
    Table 78. China Anticoagulant Sales by Application (2025-2030) & (K Units)
    Table 79. China Anticoagulant Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Anticoagulant Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Anticoagulant Sales by Type (2019-2024) & (K Units)
    Table 82. Asia Anticoagulant Sales by Type (2025-2030) & (K Units)
    Table 83. Asia Anticoagulant Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Anticoagulant Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Anticoagulant Sales by Application (2019-2024) & (K Units)
    Table 86. Asia Anticoagulant Sales by Application (2025-2030) & (K Units)
    Table 87. Asia Anticoagulant Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Anticoagulant Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Anticoagulant Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Anticoagulant Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Anticoagulant Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Anticoagulant Sales by Region (2019-2024) & (K Units)
    Table 93. Asia Anticoagulant Sales by Region (2025-2030) & (K Units)
    Table 94. Middle East, Africa and Latin America Anticoagulant Sales by Type (2019-2024) & (K Units)
    Table 95. Middle East, Africa and Latin America Anticoagulant Sales by Type (2025-2030) & (K Units)
    Table 96. Middle East, Africa and Latin America Anticoagulant Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Anticoagulant Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Anticoagulant Sales by Application (2019-2024) & (K Units)
    Table 99. Middle East, Africa and Latin America Anticoagulant Sales by Application (2025-2030) & (K Units)
    Table 100. Middle East, Africa and Latin America Anticoagulant Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Anticoagulant Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Anticoagulant Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Anticoagulant Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Anticoagulant Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Anticoagulant Sales by Country (2019-2024) & (K Units)
    Table 106. Middle East, Africa and Latin America Anticoagulant Sales by Country (2025-2030) & (K Units)
    Table 107. Bayer Company Information
    Table 108. Bayer Description and Major Businesses
    Table 109. Bayer Anticoagulant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 110. Bayer Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Bayer Recent Developments
    Table 112. Boehringer Ingelheim Company Information
    Table 113. Boehringer Ingelheim Description and Major Businesses
    Table 114. Boehringer Ingelheim Anticoagulant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 115. Boehringer Ingelheim Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Boehringer Ingelheim Recent Developments
    Table 117. Bristol-Myers Squibb Company Information
    Table 118. Bristol-Myers Squibb Description and Major Businesses
    Table 119. Bristol-Myers Squibb Anticoagulant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 120. Bristol-Myers Squibb Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Bristol-Myers Squibb Recent Developments
    Table 122. Daiichi Sankyo Company Information
    Table 123. Daiichi Sankyo Description and Major Businesses
    Table 124. Daiichi Sankyo Anticoagulant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 125. Daiichi Sankyo Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Daiichi Sankyo Recent Developments
    Table 127. Pfizer Company Information
    Table 128. Pfizer Description and Major Businesses
    Table 129. Pfizer Anticoagulant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 130. Pfizer Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Pfizer Recent Developments
    Table 132. Johnson & Johnson Company Information
    Table 133. Johnson & Johnson Description and Major Businesses
    Table 134. Johnson & Johnson Anticoagulant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 135. Johnson & Johnson Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Johnson & Johnson Recent Developments
    Table 137. Sanofi Company Information
    Table 138. Sanofi Description and Major Businesses
    Table 139. Sanofi Anticoagulant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 140. Sanofi Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Sanofi Recent Developments
    Table 142. AstraZeneca Company Information
    Table 143. AstraZeneca Description and Major Businesses
    Table 144. AstraZeneca Anticoagulant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 145. AstraZeneca Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. AstraZeneca Recent Developments
    Table 147. Eli Lilly Company Information
    Table 148. Eli Lilly Description and Major Businesses
    Table 149. Eli Lilly Anticoagulant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 150. Eli Lilly Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Eli Lilly Recent Developments
    Table 152. Keryx Biopharmaceuticals Company Information
    Table 153. Keryx Biopharmaceuticals Description and Major Businesses
    Table 154. Keryx Biopharmaceuticals Anticoagulant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 155. Keryx Biopharmaceuticals Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Keryx Biopharmaceuticals Recent Developments
    Table 157. Key Raw Materials Lists
    Table 158. Raw Materials Key Suppliers Lists
    Table 159. Anticoagulant Distributors List
    Table 160. Anticoagulant Customers List
    Table 161. Anticoagulant Market Trends
    Table 162. Anticoagulant Market Drivers
    Table 163. Anticoagulant Market Challenges
    Table 164. Anticoagulant Market Restraints
    Table 165. Research Programs/Design for This Report
    Table 166. Key Data Information from Secondary Sources
    Table 167. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anticoagulant Product Picture
    Figure 2. Global Anticoagulant Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Anticoagulant Market Share by Type in 2023 & 2030
    Figure 4. Oral Product Picture
    Figure 5. Injectable Product Picture
    Figure 6. Global Anticoagulant Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Anticoagulant Market Share by Application in 2023 & 2030
    Figure 8. DVT
    Figure 9. PE
    Figure 10. AF
    Figure 11. Anticoagulant Report Years Considered
    Figure 12. Global Anticoagulant Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Anticoagulant Revenue 2019-2030 (US$ Million)
    Figure 14. Global Anticoagulant Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 15. Global Anticoagulant Revenue Market Share by Region (2019-2030)
    Figure 16. Global Anticoagulant Sales 2019-2030 ((K Units)
    Figure 17. Global Anticoagulant Sales Market Share by Region (2019-2030)
    Figure 18. US & Canada Anticoagulant Sales YoY (2019-2030) & (K Units)
    Figure 19. US & Canada Anticoagulant Revenue YoY (2019-2030) & (US$ Million)
    Figure 20. Europe Anticoagulant Sales YoY (2019-2030) & (K Units)
    Figure 21. Europe Anticoagulant Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. China Anticoagulant Sales YoY (2019-2030) & (K Units)
    Figure 23. China Anticoagulant Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. Asia (excluding China) Anticoagulant Sales YoY (2019-2030) & (K Units)
    Figure 25. Asia (excluding China) Anticoagulant Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Middle East, Africa and Latin America Anticoagulant Sales YoY (2019-2030) & (K Units)
    Figure 27. Middle East, Africa and Latin America Anticoagulant Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. The Anticoagulant Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 29. The Top 5 and 10 Largest Manufacturers of Anticoagulant in the World: Market Share by Anticoagulant Revenue in 2023
    Figure 30. Global Anticoagulant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 31. Global Anticoagulant Sales Market Share by Type (2019-2030)
    Figure 32. Global Anticoagulant Revenue Market Share by Type (2019-2030)
    Figure 33. Global Anticoagulant Sales Market Share by Application (2019-2030)
    Figure 34. Global Anticoagulant Revenue Market Share by Application (2019-2030)
    Figure 35. US & Canada Anticoagulant Sales Market Share by Type (2019-2030)
    Figure 36. US & Canada Anticoagulant Revenue Market Share by Type (2019-2030)
    Figure 37. US & Canada Anticoagulant Sales Market Share by Application (2019-2030)
    Figure 38. US & Canada Anticoagulant Revenue Market Share by Application (2019-2030)
    Figure 39. US & Canada Anticoagulant Revenue Share by Country (2019-2030)
    Figure 40. US & Canada Anticoagulant Sales Share by Country (2019-2030)
    Figure 41. U.S. Anticoagulant Revenue (2019-2030) & (US$ Million)
    Figure 42. Canada Anticoagulant Revenue (2019-2030) & (US$ Million)
    Figure 43. Europe Anticoagulant Sales Market Share by Type (2019-2030)
    Figure 44. Europe Anticoagulant Revenue Market Share by Type (2019-2030)
    Figure 45. Europe Anticoagulant Sales Market Share by Application (2019-2030)
    Figure 46. Europe Anticoagulant Revenue Market Share by Application (2019-2030)
    Figure 47. Europe Anticoagulant Revenue Share by Country (2019-2030)
    Figure 48. Europe Anticoagulant Sales Share by Country (2019-2030)
    Figure 49. Germany Anticoagulant Revenue (2019-2030) & (US$ Million)
    Figure 50. France Anticoagulant Revenue (2019-2030) & (US$ Million)
    Figure 51. U.K. Anticoagulant Revenue (2019-2030) & (US$ Million)
    Figure 52. Italy Anticoagulant Revenue (2019-2030) & (US$ Million)
    Figure 53. Russia Anticoagulant Revenue (2019-2030) & (US$ Million)
    Figure 54. China Anticoagulant Sales Market Share by Type (2019-2030)
    Figure 55. China Anticoagulant Revenue Market Share by Type (2019-2030)
    Figure 56. China Anticoagulant Sales Market Share by Application (2019-2030)
    Figure 57. China Anticoagulant Revenue Market Share by Application (2019-2030)
    Figure 58. Asia Anticoagulant Sales Market Share by Type (2019-2030)
    Figure 59. Asia Anticoagulant Revenue Market Share by Type (2019-2030)
    Figure 60. Asia Anticoagulant Sales Market Share by Application (2019-2030)
    Figure 61. Asia Anticoagulant Revenue Market Share by Application (2019-2030)
    Figure 62. Asia Anticoagulant Revenue Share by Region (2019-2030)
    Figure 63. Asia Anticoagulant Sales Share by Region (2019-2030)
    Figure 64. Japan Anticoagulant Revenue (2019-2030) & (US$ Million)
    Figure 65. South Korea Anticoagulant Revenue (2019-2030) & (US$ Million)
    Figure 66. China Taiwan Anticoagulant Revenue (2019-2030) & (US$ Million)
    Figure 67. Southeast Asia Anticoagulant Revenue (2019-2030) & (US$ Million)
    Figure 68. India Anticoagulant Revenue (2019-2030) & (US$ Million)
    Figure 69. Middle East, Africa and Latin America Anticoagulant Sales Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Anticoagulant Revenue Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Anticoagulant Sales Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Anticoagulant Revenue Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Anticoagulant Revenue Share by Country (2019-2030)
    Figure 74. Middle East, Africa and Latin America Anticoagulant Sales Share by Country (2019-2030)
    Figure 75. Brazil Anticoagulant Revenue (2019-2030) & (US$ Million)
    Figure 76. Mexico Anticoagulant Revenue (2019-2030) & (US$ Million)
    Figure 77. Turkey Anticoagulant Revenue (2019-2030) & (US$ Million)
    Figure 78. Israel Anticoagulant Revenue (2019-2030) & (US$ Million)
    Figure 79. GCC Countries Anticoagulant Revenue (2019-2030) & (US$ Million)
    Figure 80. Anticoagulant Value Chain
    Figure 81. Anticoagulant Production Process
    Figure 82. Channels of Distribution
    Figure 83. Distributors Profiles
    Figure 84. Bottom-up and Top-down Approaches for This Report
    Figure 85. Data Triangulation
    Figure 86. Key Executives Interviewed